About Deka Biosciences
Deka Biosciences is a private company based in Germantown, Maryland. It has reported $45,738,134 raised in two offerings on Form D since November 2021. Its chief executive is John Mumm.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 6, 2023 | Dec 8, 2023 | $29,851,474of $41.3M target | 33 | $904K | EquityRule 506(b) | Form D ↗ |
| Oct 29, 2021 | Nov 23, 2021 | $15,886,660of $25.8M target | 28 | $567K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $45,738,134 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Deka Biosciences's Form D filed Dec 8, 2023.
JM
John Mumm
Chief Executive Officer and director
PK
Pavel Khrimian
Executive officer
DB
Detlev Biniszkiewicz
Director
LH
Lu Han
Director
CY
Christopher Yaen
Executive officer
Rakhshita Dhar
Director
Also a board member at NextPoint Therapeutics and a director at Recode Therapeutics and SonoThera.
PB
Peter Buzy
Director
Earlier filings also listed Vera Mumm (executive officer, last listed Nov 2021), Sally (Yuanheng) Wang (director, last listed Nov 2021), Lucio Iannone (director, last listed Nov 2021) and Christian Kanady (director, last listed Nov 2021).